Ditto Biosciences
Latest round
- Seed
Last raised
- Mar 2026
Total raised
- Undisclosed
Investors
- 1
About Ditto Biosciences
Founded in 2025 and headquartered in San Francisco, US, Ditto Biosciences focuses on drug discovery. The company has engaged in a significant pivot towards AI-driven therapies for autoimmune diseases.Ditto Bio specializes in drug discovery by leveraging biological mechanisms of parasites to target autoimmune diseases. Its core offering includes an AI platform that identifies and evaluates proteins from viruses, ticks, and worms, aiming to modulate the immune system for conditions such as rheumatoid arthritis, eczema, and multiple sclerosis.Ditto Bio's revenue model is built around partnerships with pharmaceutical companies and research organizations, focusing on B2B transactions. The company engages in collaborative agreements that allow clients to access its AI-driven platform and discoveries, typically involving licensing agreements or joint ventures with upfront fees or royalties based on the commercialization of resulting therapeutics.Looking ahead, Ditto Biosciences is focused on launching new products leveraging its AI platform in 2026. The company plans to expand into new markets in Europe and Asia by the end of 2026.
Who invested in Ditto Biosciences
1 investor across 1 round
See all investors in Ditto Biosciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Mar 16, 2026
Amount
Undisclosed
Investors
Questions about Ditto Biosciences
Who invested in Ditto Biosciences?
Ditto Biosciences has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Ditto Biosciences raised?
Ditto Biosciences has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Ditto Biosciences last raise money?
Ditto Biosciences's most recent round on record is a Seed, in Mar 2026.
What does Ditto Biosciences do?
Founded in 2025 and headquartered in San Francisco, US, Ditto Biosciences focuses on drug discovery.
Where is Ditto Biosciences headquartered?
Ditto Biosciences is headquartered in San Francisco, US.
Which VCs invest in companies like Ditto Biosciences?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Ditto Biosciences's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Ditto Biosciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.